Received Nov 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Respiratory infection; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of respiratory infection in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, less than 2 years after receiving RSV vaccine, the patient experienced respiratory infection (Verbatim: Respiratory infection). The outcome of the respiratory infection was not reported. It was unknown if the reporter considered the respiratory infection to be related to RSV vaccine. It was unknown if the company considered the respiratory infection to be related to RSV vaccine. Additional Information: GSK receipt date: 29 Oct 2025 This case was reported by a consumer via interactive digital media. Last year the patient received the RSV vaccine, the patient ended up with a bad respiratory infection. The patient refused to get another shot. The batch number was not provided, and we are unable to contact the reporter.